Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
about
MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes.Metabolic Remodeling in Diabetic Cardiomyopathy.Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot studyRole of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat?Diabetic human adipose tissue-derived mesenchymal stem cells fail to differentiate in functional adipocytes.Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot StudyOxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesHexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice.The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles.Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review.Multiorgan, Multimodality Imaging in Cardiometabolic Disease.Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability.Roles of Perivascular Adipose Tissue in the Pathogenesis of Atherosclerosis.Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
P2860
Q30239799-741DB3C5-C6D4-418A-8484-8714CA80518DQ33623469-DCA3BDF4-B9CE-4E0D-929F-CB2BA9848FB1Q37679243-981678AD-70C1-4497-97BF-1A203D698903Q38668014-4CDC4796-0684-4F82-ABF0-89383735BB91Q39138114-8C861128-05C2-4864-BBAF-2CF321D572BBQ41259429-75821109-A70A-4CDA-8959-56C6D8D64BA7Q42368137-72F3FE42-AC00-4010-ADBE-D97D2E5F9BE4Q47699796-FAC95DE1-7A0C-4B27-8F38-D1FF42FE5B26Q48248585-45A2E2ED-CE3B-4CB3-865C-D10B3792E2B2Q48258328-06C5DCAE-9109-448A-98FD-E287C3316362Q49587923-AF6F39A5-0F29-4FB1-8256-5FBD2B07CAD9Q50026688-11C8E26B-4E0F-495D-89EC-0C4B94FC1F4FQ50084370-BFEBCCAB-073B-421F-A1DF-08A57CB3ED2DQ50089084-DA2E3703-75A8-4A23-8B07-10A1F06720C8Q55154117-95D92A03-C155-430A-8AB4-41EAC1C1FB0EQ58760217-E375D1AD-C501-4D79-8581-8EAF563A3CD9
P2860
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
@en
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
@nl
type
label
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
@en
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
@nl
prefLabel
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
@en
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
@nl
P2093
P2860
P50
P1154
2-s2.0-84976421868
P1476
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
@en
P2093
Catherine Kelly
Charalambos Antoniades
Christopher Rodgers
Joanna Sellwood
Jurgen Schneider
Kieran Clarke
Masliza Mahmod
Matthew Robson
Nikant Sabharwal
Oliver Rider
P2860
P356
10.1016/J.JACC.2016.03.597
P407
P5530
P577
2016-07-01T00:00:00Z
P6179
1010302379